Medicure - News Releases

Get News Alerts by Email

Oct 3, 2017

Medicure Announces Sale of Apicore Business
Aug 7, 2017

Medicure Reports Financial Results for Quarter Ended June 30, 2017
Aug 2, 2017

Medicure Q2 Results and Conference Call Dates
Jul 12, 2017

Medicure Closes Acquisition of Additional Interests in Apicore
Jul 10, 2017

Medicure Exercises Option to Acquire Additional Interests in Apicore
Jul 3, 2017

Medicure Provides Update on Apicore Purchase Option
May 24, 2017

Medicure Reports Financial Results for Quarter Ended March 31, 2017
May 18, 2017

Medicure Q1 Results and Conference Call Dates
Apr 26, 2017

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
Mar 29, 2017

Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017
Mar 23, 2017

Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Jan 9, 2017

Medicure Provides Apicore Secured Loan to Replace Knight Loan
Dec 13, 2016

Medicure announces filing of ANDA in collaboration with Apicore
Dec 1, 2016

Medicure Closes Acquisition of Majority Interest in Apicore
Nov 18, 2016

Medicure to Hold Investor Call on November 21, 2016
Nov 18, 2016

Medicure Exercises Option to Acquire Majority Interest in Apicore
Nov 9, 2016

Medicure Reports Third Quarter 2016 Financial Results
Nov 2, 2016

Medicure to Announce Q3 2016 Financial Results on November 9, 2016
Sep 1, 2016

FDA Approves New AGGRASTAT® Product Format
Aug 10, 2016

Medicure Reports Second Quarter 2016 Financial Results
Aug 3, 2016

Medicure to Announce Q2 2016 Financial Results on August 10, 2016
Jul 7, 2016

Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication
May 11, 2016

Medicure Reports First Quarter 2016 Financial Results
May 11, 2016

Medicure Files Application for New AGGRASTAT® Product Format
May 9, 2016

Medicure Announces Departure of President and Chief Operating Officer

Show per page

print